Christopher M. McBride

584 citations
15 papers · 295 · h-index 12

Impact in

Papers in

  • Molecular Biology 13
    • Chemical Synthesis and Analysis 5
    • Melanoma and MAPK Pathways 4
  • Organic Chemistry 8
    • Quinazolinone synthesis and applications 3
    • Synthesis and biological activity 3
Co-authors
Cynthia M. Shafer (8 shared papers)Paul A. Renhowe (7 shared papers)Johanna M. Jansen (4 shared papers)Sylvia Ma (4 shared papers)Barry H. Levine (3 shared papers)Savithri Ramurthy (3 shared papers)Abran Costales (3 shared papers)Darrin D. Stuart (3 shared papers)
Journals
Bioorganic & Medicinal Chemistry Letters (7 papers)ACS Medicinal Chemistry Letters (3 papers)Tetrahedron Letters (2 papers)Journal of Medicinal Chemistry (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
Partner nations
United StatesSwitzerlandJapan

In The Last Decade

Christopher M. McBride

15 papers receiving 278 citations

Peers

Christopher M. McBride
Comparison fields: 5 of 48
  • Organic Chemistry 162
  • Computational Theory and Mathematics 48
  • Oncology 72
  • Molecular Biology 175
  • Toxicology 8
Replace Mark A. Bobko with:
Mark A. Bobko United States
Prashi Jain United States
Jesús Vázquez Spain
Dominik Hauser Germany
Taijin Wang China
Yoshiaki Washio United Kingdom
Ana S. Newton United States
Divya Pingili India
Nemanja Djoković Serbia
Paul Erdman United States
Christopher M. McBride relative to Mark A. Bobko United States Mark A. Bobko's profile →
Citations per field
00.5×2×3×4.3×
Mark A. Bobko · 1×
Citations per year

Countries citing papers authored by Christopher M. McBride

Since Specialization
Citations

This map shows the geographic impact of Christopher M. McBride's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher M. McBride with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher M. McBride more than expected).

Fields of papers citing papers by Christopher M. McBride

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher M. McBride. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher M. McBride. The network helps show where Christopher M. McBride may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher M. McBride, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher M. McBride Line = papers co-authored together Christopher M. McBride links everyone, so they are left out of the graph.

All Works

15 of 15 papers shown
#Work
1
Design and Synthesis of Orally Bioavailable Benzimidazoles as Raf Kinase Inhibitors
Journal of Medicinal Chemistry ·Savithri Ramurthy, Sharadha Subramanian, Mina Aikawa, Payman Amiri, Abran Costales, Jeff Dove, Susan Fong, Johanna M. Jansen, Barry H. Levine, Sylvia Ma, Christopher M. McBride, Jonah Michaelian, Teresa E. Pick, Daniel J. Poon, Sandhya Girish, Cynthia M. Shafer, Darrin D. Stuart, Leonard Sung, Paul A. Renhowe
200872
2
Design and structure–activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases
Bioorganic & Medicinal Chemistry Letters ·Christopher M. McBride, Paul A. Renhowe, Carla Heise, Johanna M. Jansen, Gena Lapointe, Sylvia Ma, Ramon Piñeda, Jayesh Vora, Marion Wiesmann, Cynthia M. Shafer
200640
3
Discovery of RAF265: A Potent mut-B-RAF Inhibitor for the Treatment of Metastatic Melanoma
ACS Medicinal Chemistry Letters ·Teresa E. Williams, Sharadha Subramanian, Joelle Verhagen, Christopher M. McBride, Abran Costales, Leonard Sung, William Antonios-McCrea, Maureen McKenna, Alicia K. Louie, Savithri Ramurthy, Barry H. Levine, Cynthia M. Shafer, Timothy Machajewski, Paul A. Renhowe, B.A. Appleton, Payman Amiri, James Chou, Darrin D. Stuart, Kimberly Aardalen, Daniel Poon
201535
4
3D Pharmacophore Model-Assisted Discovery of Novel CDC7 Inhibitors
ACS Medicinal Chemistry Letters ·Mika Lindvall, Christopher M. McBride, Maureen McKenna, Thomas G. Gesner, Asha Yabannavar, Kent Wong, Song Lin, Annette O. Walter, Cynthia M. Shafer
201123
5
Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 2
Bioorganic & Medicinal Chemistry Letters ·Christopher M. McBride, Zacharia S. Cheruvallath, Mallareddy Komandla, Mingnam Tang, Pamela Farrell, J. David Lawson, Darin Vanderpool, Yiqin Wu, Douglas R. Dougan, Artur Płonowski, Corine Holub, Christopher J. Larson
201618
6
3-Benzimidazol-2-yl-1H-indazoles as potent c-ABL inhibitors
Bioorganic & Medicinal Chemistry Letters ·Christopher M. McBride, Paul A. Renhowe, Thomas G. Gesner, Johanna M. Jansen, Julie Qiaojin Lin, Sylvia Ma, Yasheen Zhou, Cynthia M. Shafer
200616
7
Structure-based design and SAR development of 5,6-dihydroimidazolo[1,5-f]pteridine derivatives as novel Polo-like kinase-1 inhibitors
Bioorganic & Medicinal Chemistry Letters ·Andre A. Kiryanov, Srinivasa Reddy Natala, Benjamin Jones, Christopher M. McBride, Victoria A. Feher, Betty Lam, Yan Liu, Kouhei Honda, Noriko Uchiyama, Tomohiro Kawamoto, Yuichi Hikichi, Lilly Zhang, David J. Hosfield, R.J. Skene, Hua Zou, Jeffrey A. Stafford, Xiaodong Cao, Takashi Ichikawa
201613
8
PHARMACOLOGIC STUDIES OF CYCLOCYTIDINE AND ARABINOSYLCYTOSINE IN DOGS
Drug Metabolism and Disposition ·D H Ho, Carol J. K. Carter, Ti Li Loo, Richard L. Abbott, Christopher M. McBride
197513
9
Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 1
Bioorganic & Medicinal Chemistry Letters ·Zacharia S. Cheruvallath, Mingnam Tang, Christopher M. McBride, Mallareddy Komandla, Joanne Miura, Thu Ton-Nu, Phil Erikson, Jun Feng, Pamela Farrell, J. David Lawson, Darin Vanderpool, Yiqin Wu, Douglas R. Dougan, Artur Płonowski, Corine Holub, Christopher J. Larson
201612
10
Efficient synthesis of substituted benzenes from 1,3-dienes or 1,4-cyclohexadienes with KMnO4 under mild conditions
Tetrahedron Letters ·Christopher M. McBride, Will Chrisman, Clifford E. Harris, Bakthan Singaram
199912
11
Design and structure–activity relationship of heterocyclic analogs of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones as inhibitors of receptor tyrosine kinases
Bioorganic & Medicinal Chemistry Letters ·Kelly Frazier, Elisa M. Jazan, Christopher M. McBride, Sabina Pecchi, Paul A. Renhowe, Cynthia M. Shafer, Clarke Taylor, Dirksen E. Bussiere, Molly M. He, Johanna M. Jansen, Gena Lapointe, Sylvia Ma, Jayesh Vora, Marion Wiesmann
200611
12
Design and Synthesis of Orally Bioavailable Benzimidazole Reverse Amides as Pan RAF Kinase Inhibitors
ACS Medicinal Chemistry Letters ·Sharadha Subramanian, Abran Costales, Teresa E. Williams, Barry H. Levine, Christopher M. McBride, Daniel Poon, Payman Amiri, Paul A. Renhowe, Cynthia M. Shafer, Darrin D. Stuart, Joelle Verhagen, Savithri Ramurthy
201411
13
Structure-guided optimization of a novel class of ASK1 inhibitors with increased sp3 character and an exquisite selectivity profile
Bioorganic & Medicinal Chemistry Letters ·Simone V. Bigi-Botterill, Anthony Ivetac, Erica L. Bradshaw, Derek C. Cole, Douglas R. Dougan, Jacques Ermolieff, Petro Halkowycz, Ben Johnson, Christopher M. McBride, Jason Pickens, M. Sabat, Steven Swann
20208
14
Using Target Engagement Biomarkers to Predict Clinical Efficacy of MetAP2 Inhibitors
Journal of Pharmacology and Experimental Therapeutics ·Pamela Farrell, Christopher J. Zopf, Huey-Jing Huang, Deepika Balakrishna, Corine Holub, James Bilakovics, Andrea Fanjul, Jennifer Matuszkiewicz, Artur Płonowski, Paul Rolzin, Urmi Banerjee, Jacques Ermolieff, Zacharia S. Cheruvallath, Christopher M. McBride, Darian M. Bartkowski, Crystal Mazur, Alok S. Pachori, Christopher J. Larson
20196
15
LHMDS mediated tandem acylation–cyclization of 2-aminobenzenecarbonitriles with 2-benzymidazol-2-yl acetates: a short and efficient route to the synthesis of 4-amino-3-benzimidazol-2-ylhydroquinolin-2-ones
Tetrahedron Letters ·William Antonios-McCrea, Kelly Frazier, Elisa M. Jazan, Timothy Machajewski, Christopher M. McBride, Sabina Pecchi, Paul A. Renhowe, Cynthia M. Shafer, Clarke Taylor
20055

About Christopher M. McBride

Christopher M. McBride is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Cellular and Molecular Neuroscience and Computational Theory and Mathematics, having authored 15 papers that have together received 295 indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (5 papers), Melanoma and MAPK Pathways (4 papers), Quinazolinone synthesis and applications (3 papers), Neuropeptides and Animal Physiology (3 papers), Synthesis and biological activity (3 papers), HER2/EGFR in Cancer Research (3 papers), Peptidase Inhibition and Analysis (3 papers) and Microtubule and mitosis dynamics (2 papers). The work is most often cited by research in Organic Chemistry (162 citations), Computational Theory and Mathematics (48 citations), Oncology (72 citations), Molecular Biology (175 citations) and Toxicology (8 citations). Christopher M. McBride has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Cynthia M. Shafer, Paul A. Renhowe, Johanna M. Jansen, Sylvia Ma, Barry H. Levine, Savithri Ramurthy, Abran Costales, Darrin D. Stuart, Sharadha Subramanian and Payman Amiri. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, ACS Medicinal Chemistry Letters, Tetrahedron Letters, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark A. BobkoBreakdown of academic impact, for papers by Prashi JainBreakdown of academic impact, for papers by Jesús VázquezBreakdown of academic impact, for papers by Dominik HauserBreakdown of academic impact, for papers by Taijin WangBreakdown of academic impact, for papers by Yoshiaki WashioBreakdown of academic impact, for papers by Ana S. NewtonBreakdown of academic impact, for papers by Divya PingiliBreakdown of academic impact, for papers by Nemanja DjokovićBreakdown of academic impact, for papers by Paul Erdman